UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials

Journal of clinical oncology, 2017-03, Vol.35 (7), p.743-750

2017

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen-Induced Anorexia Is Associated With Fatty Acid Synthase Inhibition in the Ventromedial Nucleus of the Hypothalamus and Accumulation of Malonyl-CoA

Diabetes (New York, N.Y.), 2006-05, Vol.55 (5), p.1327-1336

2006

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002

Journal of clinical oncology, 2002-08, Vol.20 (15), p.3317-3327

2002

Link zum Volltext

Verfügbarkeit prüfen

Extended adjuvant tamoxifen for breast cancer—a new era?

The Lancet (British edition), 2013-03, Vol.381 (9869), p.782-783

Powles, Trevor J

2013

Link zum Volltext

Verfügbarkeit prüfen

Twenty-Year Follow-up of the Royal Marsden Randomized, Double-Blinded Tamoxifen Breast Cancer Prevention Trial

JNCI : Journal of the National Cancer Institute, 2007-02, Vol.99 (4), p.283-290

2007

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen for the Prevention of Breast Cancer: Psychosocial Impact on Women Participating in Two Randomized Controlled Trials

Journal of clinical oncology, 2001-04, Vol.19 (7), p.1885-1892

2001

Link zum Volltext

Verfügbarkeit prüfen

The Feasibility of Using Fine Needle Aspiration from Primary Breast Cancers for cDNA Microarray Analyses

Clinical cancer research, 2002-03, Vol.8 (3), p.794-801

2002

Link zum Volltext

Verfügbarkeit prüfen

Optimal Use of Adjuvant Bisphosphonates and Breast Cancer

Journal of clinical oncology, 2017-08, Vol.35 (23), p.2719-2720

2017

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Prevention

The oncologist (Dayton, Ohio), 2002-02, Vol.7 (1), p.60-64

Powles, Trevor J.

2002

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.299-306

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical Phenotype of Breast Cancer during 25-Year Follow-up of the Royal Marsden Tamoxifen Prevention Trial

Cancer prevention research (Philadelphia, Pa.), 2017-03, Vol.10 (3), p.171-176

2017

Link zum Volltext

Verfügbarkeit prüfen

Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials

Breast cancer research and treatment, 2016-08, Vol.158 (3), p.591-596

2016

Link zum Volltext

Verfügbarkeit prüfen

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial

Breast cancer research and treatment, 2001, Vol.65 (2), p.125-134

2001

Link zum Volltext

Verfügbarkeit prüfen

Selective oestrogen receptor modulators (SERMs) for prevention of breast cancer

The National medical journal of India, 2013-07, Vol.26 (4), p.194-196

Powles, Trevor J

2013

Link zum Volltext

Verfügbarkeit prüfen

Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference

Clinical cancer research, 2006-10, Vol.12 (20), p.6209s-6212s

2006

Link zum Volltext

Verfügbarkeit prüfen

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

Breast cancer research : BCR, 2002-01, Vol.4 (3), p.R3-R3, Article R3

2002

Link zum Volltext

Verfügbarkeit prüfen

Chemoprevention Options for BRCA1 and BRCA2 Mutation Carriers

Journal of clinical oncology, 2000-11, Vol.18 (suppl 1), p.93s-99s

2000

Link zum Volltext

Verfügbarkeit prüfen

Prevention of breast cancer using SERMs

Advances in experimental medicine and biology, 2008, Vol.630, p.232

Powles, Trevor J

2008

Link zum Volltext

Verfügbarkeit prüfen

The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis

Breast cancer research : BCR, 2006-01, Vol.8 (3), p.R32-R32, Article R32

2006

Link zum Volltext

Verfügbarkeit prüfen

Anti-oestrogenic prevention of breast cancer — the make or break point

Nature reviews. Cancer, 2002-10, Vol.2 (10), p.787-794

Powles, Trevor J

2002

Link zum Volltext

Verfügbarkeit prüfen

Prevention of breast cancer using selective oestrogen receptor modulators (SERMs)

Breast cancer research : BCR, 2006-01, Vol.8 (5), p.111-111, Article 111

Powles, Trevor J

2006

Link zum Volltext

Verfügbarkeit prüfen

Do we have a clinically useful breast cancer risk reduction agent for healthy women?

Nature clinical practice. Oncology, 2006-12, Vol.3 (12), p.650-651

Powles, Trevor J

2006

Link zum Volltext

Verfügbarkeit prüfen

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer

JNCI : Journal of the National Cancer Institute, 1998-05, Vol.90 (9), p.704-708

1998

Link zum Volltext

Verfügbarkeit prüfen

Anti-oestrogenic chemoprevention of breast cancer—the need to progress

European Journal of Cancer, 2003-03, Vol.39 (5), p.572-579

Powles, Trevor J.

2003

Link zum Volltext

Verfügbarkeit prüfen

American society of clinical oncology technology assessment working group update: Use of aromatase inhibitors in the adjuvant setting

Journal of clinical oncology, 2003-07, Vol.21 (13), p.2597-2599

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(126)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(87)
Life Sciences & Biomedicine
(85)
Science & Technology
(85)
Female
(81)
Oncology
(56)
Breast Cancer
(50)
Biological And Medical Sciences
(48)
Middle Aged
(48)
Medical Sciences
(47)
Breast Neoplasms - Drug Therapy
(39)
Aged
(37)
Breast Neoplasms - Prevention & Control
(34)
Adult
(29)
Chemotherapy
(29)
Pharmacology. Drug Treatments
(28)
Tamoxifen - Therapeutic Use
(28)
Antineoplastic Agents
(23)
General & Internal Medicine
(19)
Medicine, General & Internal
(18)
Double-Blind Method
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials

Tamoxifen-Induced Anorexia Is Associated With Fatty Acid Synthase Inhibition in the Ventromedial Nucleus of the Hypothalamus and Accumulation of Malonyl-CoA

American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002

Extended adjuvant tamoxifen for breast cancer—a new era?

Twenty-Year Follow-up of the Royal Marsden Randomized, Double-Blinded Tamoxifen Breast Cancer Prevention Trial

Tamoxifen for the Prevention of Breast Cancer: Psychosocial Impact on Women Participating in Two Randomized Controlled Trials

The Feasibility of Using Fine Needle Aspiration from Primary Breast Cancers for cDNA Microarray Analyses

Optimal Use of Adjuvant Bisphosphonates and Breast Cancer

Breast Cancer Prevention

Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene

Immunohistochemical Phenotype of Breast Cancer during 25-Year Follow-up of the Royal Marsden Tamoxifen Prevention Trial

Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial

Selective oestrogen receptor modulators (SERMs) for prevention of breast cancer

Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

Chemoprevention Options for BRCA1 and BRCA2 Mutation Carriers

Prevention of breast cancer using SERMs

The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis

Anti-oestrogenic prevention of breast cancer — the make or break point

Prevention of breast cancer using selective oestrogen receptor modulators (SERMs)

Do we have a clinically useful breast cancer risk reduction agent for healthy women?

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer

Anti-oestrogenic chemoprevention of breast cancer—the need to progress

American society of clinical oncology technology assessment working group update: Use of aromatase inhibitors in the adjuvant setting

Suchergebnisse filtern